Clinical trials with one type of lithium pacemaker generator.

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Device Technology

Background:

• Pacemaker technology is crucial for managing cardiac arrhythmias.
• Evaluating the long-term reliability and safety of implanted cardiac pulse generators is essential for patient care.
• Cardiac Pacemakers, Inc. (CPI) introduced solid-state, lithium-powered pulse generators.

Purpose of the Study:

• To assess the performance and reliability of CPI solid-state, lithium-powered pulse generators.
• To evaluate patient outcomes and pacemaker-related complications in a cohort receiving CPI devices.
• To determine the potential for zero pacemaker generator replacements within the warranty period.

Main Methods:

• A cohort of 100 patients received CPI pulse generators implanted by a single surgeon over 28 months.
• Follow-up data was collected for 99% of patients, totaling 1,397.55 patient-months.
• Patient age at implantation averaged 72.8 years, with mortality and pacemaker failure meticulously recorded.

Main Results:

• Eleven CPI pacemaker generators were replaced, but none were attributed to device failure.
• No deaths among the 12 deceased patients were considered pacemaker-related.
• The high reliability suggests that many patients may not require generator replacement within the device's six-year warranty.

Conclusions:

• CPI solid-state, lithium-powered pulse generators demonstrate high reliability and safety in clinical practice.
• The findings support the potential for extended device longevity, possibly eliminating the need for generator replacement within the warranty period for a significant number of patients.
• This study provides valuable data for clinicians and patients regarding the long-term performance expectations of CPI pacemakers.